tiprankstipranks
Trending News
More News >
Organogenesis Holdings (ORGO)
NASDAQ:ORGO
US Market

Organogenesis Holdings (ORGO) Financial Statements

Compare
492 Followers

Organogenesis Holdings Financial Overview

Organogenesis Holdings's market cap is currently $481.00M. The company's EPS TTM is $0.123; its P/E ratio is -38.63; Organogenesis Holdings is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $0.21. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 482.04M$ 433.14M$ 450.89M$ 467.36M$ 338.30M
Gross Profit$ 366.30M$ 326.66M$ 345.87M$ 353.16M$ 250.98M
Operating Income$ -1.28M$ 12.53M$ 22.30M$ 72.22M$ 26.70M
EBITDA$ 15.76M$ 36.03M$ 40.32M$ 87.00M$ 37.23M
Net Income$ 861.00K$ 4.95M$ 15.53M$ 94.20M$ 17.23M
Balance Sheet
Cash & Short-Term Investments$ 135.57M$ 104.34M$ 102.48M$ 113.93M$ 84.39M
Total Assets$ 497.89M$ 460.02M$ 449.36M$ 443.26M$ 290.22M
Total Debt$ 43.31M$ 119.35M$ 123.79M$ 132.30M$ 84.77M
Net Debt$ -92.26M$ 15.01M$ 21.31M$ 18.37M$ 377.00K
Total Liabilities$ 112.57M$ 181.36M$ 183.69M$ 201.92M$ 148.41M
Stockholders' Equity$ 385.32M$ 278.66M$ 265.67M$ 241.34M$ 141.81M
Cash Flow
Free Cash Flow$ 4.18M$ 6.55M$ -9.04M$ 30.76M$ -12.21M
Operating Cash Flow$ 14.21M$ 30.92M$ 24.86M$ 61.98M$ 5.47M
Investing Cash Flow$ -10.03M$ -24.36M$ -33.90M$ -31.22M$ -23.50M
Financing Cash Flow$ 27.64M$ -5.50M$ -2.20M$ -1.04M$ 42.47M
Currency in USD

Organogenesis Holdings Earnings and Revenue History

Organogenesis Holdings Debt to Assets

Organogenesis Holdings Cash Flow

Organogenesis Holdings Forecast EPS vs Actual EPS